Litcius/Paper detail

Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine

Patrick Jedlowski, Mahdieh F. Jedlowski

2021Dermatology Online Journal73 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)RashVirologyDermatologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPathologyDiseaseInfectious disease (medical specialty)OutbreakOral Health Pathology and TreatmentDermatological and COVID-19 studiesDrug-Induced Adverse Reactions
Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine | Litcius